e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The assessment of short- and long-term changes in lung function in cystic fibrosis using
129
Xe MRI
Laurie J. Smith, Alex Horsley, Jody Bray, Paul J.C. Hughes, Alberto Biancardi, Graham Norquay, Martin Wildman, Noreen West, Helen Marshall, Jim M. Wild
Source:
Eur Respir J, 56 (6) 2000441; 10.1183/13993003.00441-2020
Journal Issue:
December
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Laurie J. Smith, Alex Horsley, Jody Bray, Paul J.C. Hughes, Alberto Biancardi, Graham Norquay, Martin Wildman, Noreen West, Helen Marshall, Jim M. Wild. The assessment of short- and long-term changes in lung function in cystic fibrosis using
129
Xe MRI. Eur Respir J, 56 (6) 2000441; 10.1183/13993003.00441-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Endoscopic lung volume reduction with endobronchial valves in very low DLCO patients
A modified staged treatment algorithm using the AeriSeal System
Related content which might interest you:
Proton MRI assessment of lung structure and function in people with cystic fibrosis
Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases
Year: 2021
Longitudinal monitoring of lung microstructure with HP gas diffusion-weighted MRI in mild cystic fibrosis children
Source: International Congress 2017 – Cystic fibrosis: monitoring and biomarkers
Year: 2017
1H and 129Xe MRI to detect functional and structural lung disease in sub-clinical cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019
One-year follow-up for lung function and functional capacity in cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 183s
Year: 2005
Quantifying lung function in COPD with hyperpolarised
3
He MRI
Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation
Year: 2012
Change in functional lung MRI and multiple breath washout outcomes over one year in children with cystic fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
Oxygen enhanced MRI biomarkers of lung function in interstitial lung disease
Source: Virtual Congress 2020 – Quantitative imaging in diffuse lung disease
Year: 2020
Patterns of regional lung physiology in cystic fibrosis using ventilation magnetic resonance imaging and multiple-breath washout
Source: Eur Respir J, 52 (5) 1800821; 10.1183/13993003.00821-2018
Year: 2018
Comparison of 1H MRI and 3He MRI ventilation images in patients with cystic fibrosis and patients with lung cancer
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018
Feasibility of unsedated lung MRI in preschoolers with Cystic fibrosis – a comparison to lung function.
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Progression of structural lung damage on high resolution CT in cystic fibrosis children with stable lung function
Source: Eur Respir J 2002; 20: Suppl. 38, 209s
Year: 2002
Lung clearance index and functional MRI outcomes to assess lung disease in preschool children with cystic fibrosis
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
Functional magnetic resonance imaging and lung function tests in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
Quantitative multivolume proton-magnetic resonance imaging in patients with cystic fibrosis lung disease: comparison with clinical indicators
Source: Eur Respir J, 53 (5) 1702020; 10.1183/13993003.02020-2017
Year: 2019
Assessment of a new magnetic resonance imaging (MRI)-scoring- system for pulmonary changes in patients with cystic fibrosis (CF) – comparison with clinical parameters and high resolution computed tomography (HRCT)
Source: Annual Congress 2006 - New modalities and application in imaging of the chest
Year: 2006
Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations
Source: Eur Respir J, 50 (2) 1700244; 10.1183/13993003.00244-2017
Year: 2017
Clinical applicability of 3He and 129Xe ventilation MRI in cystic fibrosis: longitudinal follow up
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019
Detection and monitoring of lung inflammation in cystic fibrosis during respiratory tract exacerbation using diffusion-weighted magnetic resonance imaging
Source: Eur Respir J, 50 (1) 1601437; 10.1183/13993003.01437-2016
Year: 2017
Ventilation heterogeneity assessed in patients with mild cystic fibrosis and asthma using Hyperpolarised gas MRI histogram analysis
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017
Use of MRI for functional and structural assessment of interstitial lung disease
Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept